Greenleaf Trust Raises Stock Position in Kimberly-Clark Co. (NYSE:KMB)

Greenleaf Trust grew its holdings in Kimberly-Clark Co. (NYSE:KMB) by 13.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 14,957 shares of the company’s stock after purchasing an additional 1,733 shares during the quarter. Greenleaf Trust’s holdings in Kimberly-Clark were worth $2,128,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. Price T Rowe Associates Inc. MD raised its stake in shares of Kimberly-Clark by 19.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,893,146 shares of the company’s stock valued at $762,279,000 after acquiring an additional 944,920 shares in the last quarter. Wulff Hansen & CO. boosted its stake in shares of Kimberly-Clark by 13,720.0% in the 2nd quarter. Wulff Hansen & CO. now owns 641,524 shares of the company’s stock valued at $88,659,000 after buying an additional 636,882 shares during the period. Marshall Wace LLP grew its position in shares of Kimberly-Clark by 48.4% during the second quarter. Marshall Wace LLP now owns 1,545,147 shares of the company’s stock worth $213,539,000 after buying an additional 503,839 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Kimberly-Clark by 22.4% during the second quarter. Dimensional Fund Advisors LP now owns 1,934,655 shares of the company’s stock worth $267,383,000 after buying an additional 354,501 shares during the period. Finally, Capital World Investors raised its holdings in Kimberly-Clark by 17.8% in the first quarter. Capital World Investors now owns 2,269,492 shares of the company’s stock valued at $293,559,000 after acquiring an additional 342,790 shares in the last quarter. Institutional investors and hedge funds own 76.29% of the company’s stock.

Kimberly-Clark Price Performance

Shares of NYSE:KMB opened at $136.89 on Thursday. Kimberly-Clark Co. has a one year low of $116.63 and a one year high of $149.30. The stock has a market capitalization of $46.09 billion, a price-to-earnings ratio of 25.16, a PEG ratio of 2.98 and a beta of 0.39. The company has a 50-day simple moving average of $143.18 and a 200-day simple moving average of $138.66. The company has a debt-to-equity ratio of 5.59, a quick ratio of 0.58 and a current ratio of 0.85.

Kimberly-Clark (NYSE:KMB) last posted its quarterly earnings data on Tuesday, October 22nd. The company reported $1.83 EPS for the quarter, beating the consensus estimate of $1.69 by $0.14. Kimberly-Clark had a return on equity of 223.55% and a net margin of 11.28%. The firm had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $5.06 billion. During the same period in the prior year, the business earned $1.74 EPS. The firm’s revenue was down 3.5% compared to the same quarter last year. On average, analysts predict that Kimberly-Clark Co. will post 7.25 EPS for the current year.

Kimberly-Clark Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 2nd. Investors of record on Friday, September 6th were given a $1.22 dividend. The ex-dividend date of this dividend was Friday, September 6th. This represents a $4.88 dividend on an annualized basis and a yield of 3.56%. Kimberly-Clark’s dividend payout ratio (DPR) is 89.71%.

Analyst Ratings Changes

KMB has been the topic of a number of recent analyst reports. StockNews.com downgraded shares of Kimberly-Clark from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 30th. Barclays increased their target price on Kimberly-Clark from $135.00 to $144.00 and gave the company an “equal weight” rating in a report on Friday, October 11th. TD Cowen assumed coverage on Kimberly-Clark in a report on Tuesday, July 23rd. They set a “buy” rating and a $161.00 price target for the company. JPMorgan Chase & Co. dropped their price objective on Kimberly-Clark from $142.00 to $140.00 and set an “underweight” rating on the stock in a report on Wednesday. Finally, UBS Group decreased their target price on Kimberly-Clark from $153.00 to $151.00 and set a “neutral” rating for the company in a research note on Wednesday. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $149.93.

Insider Buying and Selling at Kimberly-Clark

In other news, insider Gonzalo Uribe sold 1,780 shares of the firm’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the completion of the sale, the insider now owns 7,377 shares in the company, valued at approximately $1,038,976.68. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.62% of the stock is currently owned by corporate insiders.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.